Drug Profile
Research programme: diagnostic and imaging agents - GE Healthcare/Isogenica
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator GE Healthcare; Isogenica
- Class Diagnostic agents; Imaging agents
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Undefined(Diagnosis) in USA
- 08 May 2006 Preclinical trials in Diagnostic imaging in USA (unspecified route)